STOCK TITAN

PHVS (NASDAQ: PHVS) affiliate files Form 144 to resell 9,667 restricted shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

PHVS submitted a Form 144 notice disclosing proposed sales of restricted common stock by an affiliate. The filing lists two lots of restricted shares: 4,667 shares dated 04/11/2025 and 5,000 shares dated 03/12/2026.

The broker identified is Morgan Stanley Smith Barney LLC and the filing shows an amount of $292,853.06 alongside broker and exchange details. The filing is a routine affiliate resale notice under securities rules.

Positive

  • None.

Negative

  • None.

Insights

Routine Form 144 resale notice listing two restricted-stock lots.

The filing lists proposed sales of restricted common stock in two separate lots: 4,667 shares with a 04/11/2025 date and 5,000 shares with a 03/12/2026 date. It names Morgan Stanley Smith Barney LLC as the broker.

Form 144 is a notice of intent by an affiliate to sell restricted shares; the exact method and timing of any sale depend on subsequent market transactions and compliance with transfer restrictions.

Restricted shares (lot 1) 4,667 shares dated 04/11/2025
Restricted shares (lot 2) 5,000 shares dated 03/12/2026
Amount shown $292,853.06 appears on broker/exchange line
Filing date / exchange line 05/21/2026 associated with NASDAQ line in excerpt
Restricted Stock regulatory
"Common | 04/11/2025 | Restricted Stock | Issuer"
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.
Form 144 regulatory
"Filer Information | 144: Filer Information"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Issuer financial
"Restricted Stock | Issuer | | | 4667"

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the PHVS Form 144 disclose?

The Form 144 discloses proposed sales of restricted common stock by an affiliate, listing 4,667 shares dated 04/11/2025 and 5,000 shares dated 03/12/2026, and names the broker involved.

Who is the broker listed on the PHVS Form 144?

The broker identified is Morgan Stanley Smith Barney LLC, located at 1 New York Plaza, 8th Floor, New York, NY. The filing pairs the broker with exchange listing information.

What monetary figure appears in the PHVS filing?

The filing shows a monetary figure of $292,853.06 associated with the broker/exchange line. The excerpt does not tie that figure to a labeled proceeds statement.

Does the Form 144 specify trading methods or timing for PHVS shares?

The excerpt lists the restricted-stock lots and dates but does not state specific trading methods or a concrete execution timeline for sales of the disclosed shares.